Attack the Disease, Not the Immune SystemTM


Join Us in Shaping the Future of Medicine:
Opportunities for
Investors & Partners
Management Team
Significant Unmet Need



Unique Platform



Clinically Proven
STA-528, an allosteric inhibitor, specifically blocks STAT3-SH2 (Y705)
activation. Rather than suppressing immune function, it balances the immune system to bolster and maintain the body’s ability to fight disease.
- STA-528 restores immune homeostasis, possibly
leading to complete remission – or potentially even
cure
- STA-528 suppresses pro-inflammatory Th17/Th1

Path to Market
Focus is on Two Rare Autoimmune/Inflammatory Diseases
- ALPS
Autoimmune Lymphoproliferative Syndrome
- MCTD
Mixed Connective Tissue Disease

Pipeline

Leading Innovation in Autoimmune Disease



